Oric Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(7.562%),Abigail P. Johnson(7.562%)
Oric Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chacko Jacob
Oric Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(8.9%),Oleg Nodelman(8.9%), etc.
Oric Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alkeon Capital Management, LLC(6.6%),Panayotis D. Sparaggis(6.6%)
Oric Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Prosight Management, LP(2.9%),Prosight Partners, LLC(2.9%), etc.
Oric Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(12.835%),Abigail P. Johnson(12.835%)
Oric Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chacko Jacob
Oric Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.5%)
Oric Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(0.0%),Millennium Group Management LLC(0.0%), etc.
Oric Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Venrock Healthcare Capital Partners III, L.P.(6.6%),VHCP Co-Investment Holdings III, LLC(6.6%), etc.
Oric Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Viking Global Investors LP(5.9%),Viking Global Opportunities Parent GP LLC(5.9%), etc.
Oric Pharmaceuticals | D: Filing D
Oric Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.7%)
Oric Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-James N. Topper(6.2%),Patrick J. Heron(6.2%), etc.
Oric Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Piscitelli Dominic
Oric Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chacko Jacob
Oric Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Multani Pratik S
Oric Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Multani Pratik S
Oric Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Piscitelli Dominic
Oric Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chacko Jacob
No Data